Industries de la santé
Actinium Pharmaceuticals Announces Filing of Provisional Patent Application Related to Commercial Scale Labeling and Processes for Iomab-B
09 Mars 2016
Company's Patent Portfolio Continues to Expand as Programs Progress |NEW YORK, NY (Marketwired) 03/08/16
Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) ("Actinium"), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers announced today that it has filed a provisional patent application with the United States Patent...
Plus d'articles...
- Présentation de MEDIAN Technologies à la 36ème conférence annuelle Health Care de Cowen and Company
- Global Electrosurgical Devices Market to Grow Steadily to $5.56 Billion by 2021, says GlobalData
- Breast Cancer is Only Pharmaceutical Pipeline with over 1000 Drugs in Development, says GBI Research
- Onxeo annonce l'acquisition de DNA Therapeutics et fait un point sur le développement clinique de Validive®